Fig. 5: Survival curves of pediatric AML patients according to different FLT3/ITD AR and SCT status.

A Probability of EFS for patients with low FLT3/ITD AR according to SCT status. B Probability of OS for patients with low FLT3/ITD AR according to SCT status. C Probability of EFS for patients with high FLT3/ITD AR according to SCT status. D Probability of OS for patients with high FLT3/ITD AR according to SCT status. AML acute myeloid leukemia, SCT stem cell transplantation, CR complete remission, AR allelic ratio, EFS event-free survival, OS overall survival. EFS and OS were evaluated by the Kaplan–Meier method and compared by log-rank test. Source data are provided as a Source Data file.